Human β-defensin 3 (hBD3) is a cationic peptide with immunomodulatory effects on both innate and acquired immune responses. Periodontitis, an inflammatory disease that extends deep into periodontal tissues, causes the loss of supporting structures around the tooth. The present study assessed the effects of hBD3 as a monotherapy for periodontitis in mice and explored its potential mechanism. In vivo, hBD3 inhibited the levels of tumour necrosis factor (TNF)-α, interleukin-6, and matrix metalloprotease-9 in periodontium exposed to Porphyromonas gingivalis (P.g) in a mouse periodontitis model; reduced osteoclast formation and lower alveolar bone loss were also observed. In addition, hBD3 was related to the expression of polarization signature molecules in circulating monocytes. In vitro, hBD3 notably suppressed the production of TNF-α and interleukin-6 in RAW 264.7 cells stimulated by the lipopolysaccharide of P.g. Moreover, hBD3 attenuated polarization of RAW 264.7 cells into the M1 phenotype, with reduced activation of nuclear factor-κB signal transduction. In conclusion, hBD3 exhibits potent anti-periodontitis properties both in vitro and in vivo, and this effect may be correlated to inhibition of the nuclear factor-κB pathway and macrophage polarization.
Introduction
Inflammation that extends deep into the periodontal tissues and causes loss of supporting connective tissue and alveolar bone is known as periodontitis (Pihlstrom et al., 2005) . This disease is induced by polymicrobial synergy, among which Porphyromonas gingivalis (P.g) is the best characterised periodontopathogen (Socransky et al., 1998 (Socransky et al., , 1999 . P.g uses several strategies to interact with the host defence system (Darveau, 2010) . It has been demonstrated that lipopolysaccharide (LPS) produced by P.g frequently ligates with Toll like receptor-2 (TLR2), in contrast to TLR4 binding to LPS in Escherichia coli (Coats et al., 2009 ). P.g-LPS triggers robust inflammatory responses in host cells by inducing the production of chemokines and cytokines (Jung et al., 2009) , such as monocyte chemoattractant protein-1 (MCP-1), interleukin-6 (IL-6) (Trindade et al., 2013) , tumour necrosis factor alpha (TNF-α), and IL-10 (Liu et al., 2014a) . These cytokines are produced by numerous immune cells and non-immune cells, including macrophages, B cells, and periodontal ligament cells (Gordon, 1998; Mihara et al., 2012; Rincon, 2012; Shindo et al., 2016) . The high production of cytokines may in turn induce the expression of various matrix metalloproteinases (MMPs), including MMP-9 (Kothari et al., 2014) , leading to the degradation of extracellular matrix components and subsequent destruction of periodontal tissues (Yamaguchi and Kasai, 2005) .
Macrophages, as integral components of the host defence system, play important roles in the pathogenesis of periodontitis: 1) mediating the innate immune response; 2) regulating tissue repair and destruction; 3) activating adaptive immunity; and 4) mediating alveolar bone loss (Hasturk et al., 2012; Sima and Glogauer, 2013) . Macrophages can be polarised into two main phenotypes in response to different types of stimuli: the classical proinflammatory M1 type and alternative antiinflammatory M2 type (Barrett et al., 2015) . An imbalance of M1/M2 macrophages can lead to localized diseases, such as periodontitis and systemic diseases (Zhou et al., 2014) . M1 macrophages exhibit upregulation in inducible nitric oxide synthase (iNOS) and can defend against pathogens by secreting TNF-α and other pro-inflammatory mediators, which may result in tissue damage. In contrast, upregulation of arginase 1 (Arg 1) expression is observed in M2 macrophages, which secrete higher levels of IL-10 to promote wound healing (Rath et al., because of their activity against a broad spectrum of pathogenic microbes including gram-negative and gram-positive bacteria, fungi, and viruses, by binding to and forming pores in the plasma membrane of pathogens (Saitoh et al., 2007; Sudheendra et al., 2015; Lee et al., 2013) . Moreover, hBD3s has strong chemotactic activity towards immune cells and activate and amplify the adaptive immune response, thereby connecting innate and adaptive immunity (Dhople et al., 2006; Wu et al., 2003) . Clinical studies have suggested that in periodontitis, the expression levels of hBD3 in both gingival tissue and gingival crevicular fluid are reduced (Ebrahem, 2013; Liu et al., 2014b) . We previously showed that hBD3 regulates proinflammatory mediator expression in response to P.g-LPS by attenuating the phosphorylation of p38 and extracellular signal-related kinase 1/2 in the mitogen-activated protein kinase pathway in an atherosclerosis animal model Li et al., 2016) . However, the role of hBD3 in periodontitis development and the underlying mechanism remain unknown.
In this study, we induced experimental periodontitis in mice using P.g, and explored the effects of hBD3 on the periodontal immune response in vivo. In vitro, we investigated the modulating effects of hBD3 in P.g-LPS-treated RAW 264.7 cells to understand the potential mechanism by which hBD3 modulates periodontitis development.
Materials and methods

In vivo
Animals and bacteria
Sixty-four 9-week-old male apoE −/− mice (purchased from Peking University Health Science Center, Peking, China) were included in the study. All animals were housed in individual cages under controlled temperatures (24 ± 1.0°C) with a 12-h light/dark cycle and were provided free access to standard laboratory mice chow and aseptic water. All experiments were performed in accordance with the policies and guidelines for institutional animal care of Nanjing University, Nanjing, China (no. SYXK 2009-0017). P.g 33277 was cultured overnight in brain heart infusion broth supplemented with hemin and menadione in an anaerobic environment. The concentration of bacteria was measured by evaluating optical density at 600 nm (OD = 1, corresponding to 10 9 bacteria/mL) and adjusted to 10 9 /mL by dilution with phosphate-buffered solution (PBS).
Experimental protocols
First, we explored the effects of long-term administration of hBD3 by intraperitoneal injection on periodontitis. Mice in each group were randomly assigned, using a computer-generated table, to different treatments (n = 8 per group): no-treatment control (Con group); experimental periodontitis (EP group); sterile phosphate-buffered saline (PBS) treatment (PBS group), or recombinational hBD3 (Peprotech, Rocky Hill, NJ, USA) treatment (BD3 group). To induce experimental periodontitis, maxillary second molars (M2) on both sides in a submarginal position from each mouse in all groups, except the Con group, received 5-0 sutures (Jinghuan Medical Appliance, Yang Zhou, China) that had been soaked in medium containing 10 9 /mL live P.g for 2 h hBD3 was purchased from PeproTech (Rocky Hill, NJ, USA). The lyophilized product of hBD3 was reconstituted in 10 mM acetic acid to a concentration of 200 μg/mL and further diluted in PBS to a final concentration of 40 μg/mL, according. PBS and hBD3 (0.5 mg/kg, approximately 10 μg/mouse) were injected intraperitoneally three times per week. Ten weeks later, the mice were sacrificed and the tissues and blood were harvested.
Based on the results of long-term observation, we conducted a shortterm experiment to explore the effect of hBD3 delivered through periodontal pockets on periodontitis in mice (Fig. 1) . Thirty-two randomly selected mice were divided into four groups according to the following treatments applied through periodontal pockets to M2: no-treatment control (Con); experimental periodontitis (EP); ligature removed at 7 days with (BD3), or without (N) irrigation of periodontal pockets with 50 μL of 40 μg/mL hBD3 solution at 48, 96, and 144 h later. Periodontitis was induced by 5-0 ligatures exposed to P.g. Ligatures in the N and BD3 groups were removed after 7 days; 48, 96, and 144 h later, periodontal pockets around M2 in the BD3 group were irrigated with 50 μL hBD3 solution, followed by incubation for 5 min. Thirty days later, the mice were sacrificed and the maxillaries were harvested.
For all procedures, the mice were anesthetized with pentobarbital sodium (70 mg/kg; Nanjing SenBeiJia Biological Technology Co., Ltd., Nanjing, China) and atropine sulphate monohydrate (6 mg/kg; Tianjin KingYork Amino Acid Co., Ltd., Tianjin, China) via peritoneal injection. At the end, all animals were treated with an overdose of isoflurane.
Micro-CT analysis
The maxillary jaws were hemisected and the right half of the block samples (N = 8) was fixed in 4.0% paraformaldehyde and subjected to routine microcomputed tomography (micro-CT) (Bruker microCT, Kontich, Billerica, MA, USA) to evaluate alveolar bone loss and for D. Cui et al. Molecular Immunology 91 (2017) [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] histological analysis. Computed tomography was conducted using a slice thickness of 18 μm, voltage of 50 kV, and electrical current of 455 μA. Three-dimensional images were acquired using the Bruker microCT version 1.1. The distance from the cement-enamel junction to the alveolar bone crest at the palatal groove site of M2 was measured .
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Histology and immunohistochemical analysis
After micro-CT scanning, the right maxillary jaws were decalcified in 10% EDTA solution, which was exchanged every other day, for 1 month. Next, the samples were dehydrated, embedded in paraffin blocks, and cut into 3-μm sections. After dewaxing and rehydration, the sections were stained with haematoxylin and eosin or subjected to immunohistochemical analysis with goat polyclonal anti-MMP-9 (1:15, Cat number: AF909, R & D Systems, Minneapolis, MN, USA) and rabbit polyclonal anti-CD68 (1:100, Cat number: ab125212, Abcam, Cambridge, UK) Li et al., 2016) . A trained examiner, who was blinded to the treatment, examined the sections for immunohistochemical analyses. Each section was measured three times by the same examiner. A microscope with a camera mounted on a computer (1 × 71, Olympus Co., Tokyo, Japan) was used. Three histological sections from each mouse were used. Three visual fields at 400× magnification from each section with most positive cells were photographed. The number of immuno-positive cells was counted in the entire area of each photograph by software (Image-Pro Plus v6, Media Cybernetics, USA).
TRAP staining
For TRAP staining, sections were soaked in TRAP dye (Wuhan Goodbio Technology Co., Ltd., Wuhan, China) for 50 min at 37°C. After washing in PBS and visualising with 3,3-diaminobenzidine for 3 min, all sections were stained with haematoxylin and eosin for 20 s and rinsed in running water. The sections were evaluated using a microscope with a camera mounted on a computer (1 × 71, Olympus Co.) by a single examiner who was blinded to the treatment assignment. Four different visual fields from each section were evaluated, and TRAPpositive multinucleated osteoclasts were quantified and total cell counts were calculated. The values were expressed as the numbers of TRAPpositive multinucleated osteoclasts.
Isolation of circulating mononuclear cells
Circulating mononuclear cells were isolated from the blood using the Histopaque (Sigma, St. Louis, MO, USA)-density centrifugation method (Miyajima et al., 2014) . The monocyte layer was collected, washed with PBS, and stored at −20°C for PCR analysis.
Quantitative real-time PCR
Total RNAs isolated from left maxillary and monocytes were extracted using the Column Animal RNAout kit (Cat number: 71201-50, Tiandz, Inc, Beijing, China) according to the manufacturer's instructions and reverse-transcribed into cDNA using the PrimeScript™ 1 st Strand cDNA Synthesis kit (Takara, Shiga, Japan) according to the manufacturer's instructions. Primers for TNF-α, IL-6, IL-10, MMP-9, Arg-1, and iNOS (Table 1) were designed using Oligo Explorer software (1.1.0) and synthesised by Genscript Co. (Nanjing, Jiangsu, China). Real-time RT-PCR analysis was performed by SYBR Green-based assays using the Stratagene MxPro-Mx3005P System (Agilent Technologies, Santa Clara, CA, USA). PCRs were conducted with 2 μL of diluted cDNA samples and 200 nM of each forward and reverse primer in a 20-μL final reaction mixture with Platinum SYBR Green qPCR SuperMix-UDG (Invitrogen, Carlsbad, CA, USA). The internal reference gene GAPDH was used as an endogenous control. The PCRs for each gene were initiated by activation at 95°C for 2 min, followed by 40 PCR cycles of denaturation at 95°C for 15 s and annealing and extension at 60°C for 30 s. The results were analysed using MxPro 4.10 software.
2.2. In vitro study 2.2.1. Cell culture and reagents RAW 264.7 macrophage cells obtained from American Type Culture Collection (Manassas, VA, USA) were cultured as described in our previous study . Experimental wells were treated P.g-LPS (1 μg/mL) (Invivogen, San Diego, CA, USA) in the presence or absence of hBD3 (20 μg/mL) followed by further incubation for 2 h. These cells were collected and stored for PCR, nitrate reductase, and western blot assays.
Total RNA isolated from cells was extracted using TRIzol reagent (Invitrogen) according to the manufacturer's instructions and reversetranscribed into cDNA. Primers for MCP-1, TNF-α, IL-6, TLR-2, TLR-4, iNOS, and IL-10 are listed in Table 1 . Real-time-PCR analysis was performed by SYBR Green-based assays. The results were analysed using MxPro 4.10 software.
Western blot assays
Total protein from RAW 267.4 cells was extracted and separated by SDS-PAGE and then transferred to polyvinylidene fluoride membranes for 30 min at 16 V in transfer buffer . The blot was then incubated in blocking solution for 2 h before incubation with specific primary antibodies (1:1000, Cell Signaling Technology, Danvers, MA, USA). β-Actin was used as an internal control. After incubation with secondary antibodies, the blot was detected with a chemiluminescence kit. Photographs were captured using the ImageQuant LAS 4000 digital imaging system (GE Healthcare, Little Chalfont, UK).
Statistical analyses
Data are expressed as the means ± SD. SPSS 22.0 software was used to evaluate data sets to detect a normal distribution (SPSS, Inc., Chicago, IL, USA). Differences between two groups were assessed using the unpaired two-tailed Student's t-test, unless otherwise noted. MannWhitney U test was used when data sets were not normally distributed. Data sets involving more than two groups were assessed by one-way analysis of variance followed by Bonferroni correction for multiple comparisons. The differences were considered significant if P < 0.05.
Results
In the present study, we set up an experimental periodontitis model in mice to assess the effect of hBD3 delivered intraperitoneally or in periodontal pockets on the process of periodontal inflammation. For a better understanding of the immunomodulatory role of hBD3, RAW 264.7 cells were stimulated with P.g-LPS with or without the presentation of hBD3. The polarization signature molecules and cytokines expressed by the cells were then detected as in vivo study. Table 1 Primers used for real-time RT-PCR.
Genes
Forward Primers 5′-3′ Reverse Primers 5′-3′ Molecular Immunology 91 (2017) 65-74 3.1. hBD3 administrated intraperitoneally reduced alveolar bone loss and influenced the expression of polarization signature molecules in circulating mononuclear cells
Bone height was measured at the palatal groove site of M2 (Fig. 2 ). Significant alveolar bone loss was observed in the EP group. hBD3 significantly reduced alveolar bone loss in mice with periodontitis compared to that in mice treated with PBS (P < 0.05) ( Fig. 2A and B) .
We measured both M1 (TNF-α and iNOS) and M2 (Arg-1 and IL-10) macrophage polarization signature molecules in circulating monocytes (Fig. 3) , and found that hBD3 administered via intraperitoneal injection significantly reduced the expression levels of TNF-α elevated by periodontitis (P < 0.05). iNOS expression levels were slightly increased in the EP group and decreased in the BD3 group, but the difference was not significant. Arg-1 and IL-10 levels were enhanced by hBD3 (P < 0.05).
3.2. hBD3 delivered through periodontal pockets reduced alveolar bone loss and the number of osteoblast in periodontium
In the short-term study, we observed a dramatic effect of hBD3 applied through periodontal pockets on alveolar bone preservation (P < 0.05) ( Fig. 4A and B) . The results of TRAP staining ( Fig. 4A and C) suggested that in the short-term experiment, the number of osteoclasts increased significantly in mice with periodontitis compared to that in the Con group. hBD3 treatment significantly reduced the number of osteoclasts.
hBD3 delivered through periodontal pockets reduced the expression of periodontitis-related molecules
We investigated whether hBD3 irrigated in periodontal pockets could reduce the expression level of MMP-9 in periodontal tissues ( Fig. 5A-C) . According to the results of immunohistochemical analysis and RT-PCR, MMP-9 expression was significantly increased in the EP and N groups compared to that in the Con group. Application of hBD3 significantly reduced MMP-9 levels in the periodontal tissue, indicating that hBD3 can decrease inflammation in periodontal tissues. In addition, CD68-positive cells were detected in periodontal tissues (Fig. 5D) . It has been reported that CD68 is restricted to cells of myeloid lineage, particularly monocyte/macrophages (Hume, 2011) .
We further analysed periodontitis-related mRNA expression in periodontal tissue of experimental animals in all four groups in a shortterm experiment (Fig. 5E-G) . mRNA expression of TNF-α was increased in the EP and N groups compared to that in the Con group. After irrigation of hBD3, TNF-α and IL-6 expression levels were notably reduced. Expression of IL-6 increased significantly in the EP and N groups compared to that in the Con group. After hBD3 application, the mRNA expression of both molecules decreased. Expression of IL-10 increased in the EP and N groups, but the increase was not significant. After hBD3 therapy, the IL-10 level increased significantly. Fig. 2 . hBD3 administered by intraperitoneal injection inhibited alveolar bone loss in mice with experimental periodontitis. Results of microCT and HE (A). Con, no-treatment control; EP, ligature-induced periodontitis; PBS, treated with PBS; BD3, treated with hBD3; B, buccal surface; P, palatal surface; R, root; AB, alveolar bone. Scale bars of micro-CT images, 1 mm; HE images: 100 μm. Average distance from cemento-enamel junction to the alveolar bone crest of M2 at palatal groove site was calculated (B). All results are expressed as the mean ± SD. Differences between two groups were compared by unpaired Student's t-test or Mann-Whitney U test. *, P < 0.05.
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hBD3 exhibited anti-inflammatory effects in P.g-LPS-stimulated macrophages
The mRNA expression levels of MCP-1, TNF-α, and IL-6 in RAW 264.7 cells are shown in Fig. 6 . Both TNF-α and IL-6 were significantly upregulated in the P.g-LPS group compared to that in the control group (P < 0.05). Suppressive effects of hBD3 on these responses were observed in the P.g-LPS + hBD3 group (P < 0.05). The proinflammatory effect of P.g-LPS and anti-inflammatory effect of hBD3 was also observed in terms of MCP-1 production, but the differences were not significant (P > 0.05). We further determined the phosphorylation level of the NF-κB p65 subunit in nuclear fractions to evaluate the activation of this signalling pathway; the data are shown in Fig. 7 . Two hours of stimulation with P.g-LPS significantly elevated the phosphorylated protein level of the p65 subunit (P < 0.05) (Fig. 7C and D) . In contrast, in the P.g-LPS + hBD3 group, this stimulatory effect was clearly inhibited by hBD3 (P < 0.05). To clarify the upstream receptor of this signalling pathway regulated by hBD3, the relative expression levels of TLR2 and TLR4 mRNA were measured ( Fig. 7A and B) . Both hBD3 and P.g-LPS significantly increased the TLR2 mRNA level compared to that in the control group (P < 0.05), playing a synergistic role in the upregulation of TLR2 mRNA in the P.g-LPS + hBD3 group. However, transcription of TLR4 was not affected by hBD3 or P.g-LPS alone (P > 0.05). Interestingly, the TLR4 mRNA level in the P.g-LPS + hBD3 group was significantly lower than that in the P.g-LPS group (P < 0.05).
hBD3 modulated macrophage polarization upon P.g-LPS stimulation
We evaluated the polarization of M1 macrophages by detecting the mRNA expression levels of the marker molecules iNOS (Fig. 8A ) and TNF-α (Fig. 6B) . P.g-LPS significantly upregulated the mRNA levels of iNOS and TNF-α compared to that in the control group (P < 0.05). This up-regulatory effect of P.g-LPS was also observed for the expression of NO (Fig. 8B) , the enzymatic synthesis product of iNOS. P.g-LPS increased the mRNA expression level of IL-10, while its up-regulatory effect on the expression of Arg-1, a specific marker of M2 macrophages, was not significantly enhanced by P.g-LPS (P > 0.05). The effect of hBD3 on macrophage polarization in this study was in contrast to that of P.g-LPS. hBD3 significantly induced Arg-1 (Fig. 8C ) and IL-10 ( Fig. 8D) mRNA expression, regardless of the presence or absence of P.g-LPS (P < 0.05). Moreover, hBD3 down-regulated the mRNA expression of iNOS and TNF-α and inhibited the up-regulation of TNF-α mRNA and NO induced by P.g-LPS (P < 0.05).
Discussion
Clinical researchers detected the potential role of hBD3 in the pathogenesis of periodontal inflammation because it is widely present in both gingival tissues and gingival crevicular fluid, and it shows altered expression in subjects with periodontal diseases (Lu et al., 2005; Wang et al., 2011; Turkoglu et al., 2010; Liu et al., 2014b; Brancatisano et al., 2011) . hBD3 has been shown to activate myeloid dendritic cells and monocytes with increased expression of costimulatory molecules and phosphorylation of NF-B p65 (Funderburg et al., 2007) . Periodontal pathogens, such as P.g, can induce the expression of hBDs in periodontal pocket epithelial cells (Vankeerberghe et al., 2005) . It has been demonstrated that hBD3 had a beneficial effect on wound healing (Gibson et al., 2012; Alibardi et al., 2012; Sheng et al., 2014; Hirsch et al., 2009 ). According to Wang et al., hBD3 can promote fibroblast attachment and proliferation onto the diseased root surfaces (2011). However, the effect of hBD3 on periodontitis has not been directly demonstrated. Our previous studies suggested that hBD3 participates in the immune response via macrophages, which are essential in the initial host defence system during periodontal pathological progress and are critical for inflammation and tissue repair (Sima and Glogauer, 2013; Alberto et al., 2013) . ApoE −/− mice were used as a periodontitis model. We predicted that there is a significant correlation between the dysfunction of lipid metabolism and modification of innate immune activities in response to LPS in vivo (Chen et al., 2013) . Our previous study also demonstrated that these mice exhibited more serious immunoreactions compared to wild-type mice (Lyu et al., 2017) . In a study by Li et al., dysfunction of lipid metabolism exacerbated inflammation and bone loss in periodontitis (Li et al., 2015) . In this study, to establish a severe periodontitis model in a limited period, we induced periodontitis in apoE −/− mice rather than in C57BL/6 mice. And the effect of hBD3 on periodontitis was tested in mice with dysfunction of lipid metabolism. Fig. 3 . Expression of polarization signature molecules in circulating monocytes of mice in the long-term experiment. Con, no-treatment control; EP, ligature-induced periodontitis; PBS, treated with PBS; BD3, treated with hBD3. Next, circulating monocytes were collected to measure mRNA expression levels of TNF-α (A), iNOS (B), Arg-1 (C), and IL-10 (D) by PCR. Data are shown as the mean ± SD of three independent experiments. Differences between two groups were compared by unpaired Student's t-test. *, P < 0.05.
In this study, hBD3 was first administrated by intraperitoneal injection, a common technique that safely delivers a substance into the peritoneal cavity. Small molecules, such as hBD3, can enter systemic circulation through the peritoneum and then gain access to the periodontium. Periodontal pocket delivery is widely used in clinical settings. Antibiotics and other molecules spread into inflamed tissues through the epithelium and take effect. Our data demonstrated that hBD3 suppressed periodontal inflammation and alveolar bone loss in P.g-treated mice with experimental periodontitis. Considering that it is more reliable to use the palatal side for measurements of bone loss (Abe and Hajishengallis, 2013) , bone height at the palatal groove site in each group was evaluated in the present study. Less alveolar bone loss was observed after hBD3 irrigation into the periodontal pockets. Additionally, significant decreases in TNF-α and IL-6 expression levels in situ were observed in hBD3-treated mice with periodontitis. These results indicate an anti-inflammatory effect of hBD3 in periodontitis.
Furthermore, fewer osteoclasts were detected in hBD3-treated mice, explaining the suppression of alveolar bone loss. Recent studies demonstrated that P.g induces inflammation by exerting community-wide effects on periodontal pathogens and host immunity (Darveau et al., 2012) . When an imbalance in biofilm invasion and host response occurs, excess inflammatory cytokines such as TNF-α, IL-6, and MMP-9 are released, which destroy periodontal tissues (Hajishengallis, 2014; Cui et al., 2016; Graves and Cochran, 2003) . Interestingly, TNF-α Fig. 4 . hBD3 applied in periodontal pockets alleviated alveolar bone loss and reduced osteoclast formation. Results of micro-CT, HE, and TRAP staining (A). Con, no-treatment control; EP, ligature-induced periodontitis; N, ligature removed at 7 days and no treatment followed; BD3, irrigation with 50 μL of hBD3 solution at 0, 48, and 96 h after removal of ligatures; B, buccal surface; P, palatal surface; R, root; G, gingiva; CT, connective tissue; AB, alveolar bone. Scale bars of micro-CT images, 1 mm; HE images: 100 μm; TRAP staining: 50 μm. Blue lines in HE images: horizon of cemento-enamel junction; green lines: alveolar bone crest. Arrows in TRAP staining images: TRAP-positive osteoclasts. Average distance from cemento-enamel junction to the alveolar bone crest of M2 at palatal groove site was calculated (B). All results are expressed as the mean ± SD. Differences between two groups were compared by unpaired Student's t-test or Mann-Whitney U test. *, P < 0.05. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) D. Cui et al. Molecular Immunology 91 (2017) [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] activation is known to stimulate the degradation of the connective tissue matrix, activation of osteoclasts, and resorption of bone (Zhao et al., 2012; Azuma et al., 2000) . IL-6 is thought to be an important marker of periodontitis (Mendonca et al., 2014; Sharma et al., 2011) . The expression levels of MMP-9 decrease correspondingly, leading to less breakdown of periodontal tissues and alveolar bone (Yamaguchi and Kasai, 2005) . Therefore, hBD3 contributed greatly to the management of periodontitis by down-regulating the expression of TNF-α, IL-6, and MMP-9. We also predicted that the protective role of hBD3 in periodontal tissues is correlated with the up-regulation of IL-10. According to Gaddis et al., IL-10 was important for infection control and the progression of periodontal disease (Gaddis et al., 2013) . P.g-LPS interacts with host-expressed Toll-like receptors (TLRs), which are key control elements in the innate immune response. Activation of TLR leads to nuclear translocation of NF-κB and induction of inflammation-related genes. Thus, exaggerated inflammation mediated by TLRs may be a driving factor in periodontal disease (Takeda and Akira, 2004) . IL-10 is one of the most effective suppressors of TLR-induced inflammatory cytokine production and inhibits innate immune cells by directly inhibiting cytokine transcription (Curtale et al., 2013) . In addition, according to Kothari et al. (2014) , IL-10 may block IL-6-induced MMP-9 expression.
Notably, CD68+ cells were detected in infected periodontal tissues. This suggests that macrophages play important roles in the innate immune response, but may also be responsible for tissue breakdown in Periodontitis was induced in mice by placement of ligatures around upper 2nd molars with inoculation of periodontal pathogen P. gingivalis. Levels of MMP-9 (C), TNF-α (E), IL-6 (F), and IL-10 (G) in the periodontium were measured by qPCR. All results are expressed as the mean ± SD. Differences between two groups were compared by unpaired Student's t-test or MannWhitney U test. *, P < 0.05. Fig. 6 . hBD3 modulated proinflammatory mediator production in macrophages. RAW 264.7 cells were treated with blank DMEM (as control), hBD3 (10 μg/mL), P.g-LPS (1 μg/mL), or P.g-LPS (1 μg/mL) + hBD3 (10 μg/mL) for 2 h. Next, the culture supernatants were collected to measure mRNA expression levels of MCP-1 (A), TNF-α (B), and IL-6 (C) by PCR. Data are shown as the mean ± SD of three independent experiments. Differences between two groups were compared by unpaired Student's t-test or Mann-Whitney U test. *, P < 0.05. D. Cui et al. Molecular Immunology 91 (2017) 65-74 periodontal disease (Graves, 2008) . We also explored the immune response of macrophages in periodontitis. Furthermore, the anti-inflammatory effect of hBD3 on P.g-LPS-stimulated macrophages was examined to determine the underlying potential mechanism. The data in the present study showed that hBD3 not only suppressed the expression of proinflammatory mediators induced by P.g-LPS, but also potently affected M2 macrophage polarization, in agreement with observations of our previous study (Lyu et al., 2017) . In vitro, we stimulated the murine macrophage cell line, RAW 264.7 cells, with P.g-LPS and found that the mRNA expression of MCP-1, TNF-α, and IL-6 increased after stimulation, indicating the onset of an inflammatory response. Exaggerated inflammation mediated by TLRs may be a driving factor in periodontal disease (Takeda and Akira, 2004) . In this study, up-regulated TNF-α and IL-6 expression in macrophages treated with P.g-LPS was similar to that identified in the gingival tissue of the periodontitis group. This correlation in cytokine expression highlights the role of macrophages in the progression of periodontitis. Expression levels of TNF-α and IL-6 stimulated by P.g-LPS were suppressed by hBD3, in agreement with our previous study Lyu et al., 2017) . hBD3 inhibited phosphorylation of the NF-κB signalling pathway activated by P.g-LPS, suggesting that this protein protects the periodontium by inhibiting the inflammatory response of macrophages. According to our results, neither P.g-LPS nor hBD3 affected the mRNA expression of TLR4, a classical upstream receptor of E. coli-LPS on the cell surface. However, interestingly, hBD3 decreased the TLR4 mRNA level in the P.g-LPS + hBD3 group. Numerous studies have reported Fig. 7 . Activation of TLRs/NF-κB signalling pathway in macrophages. RAW 264.7 cells were treated with blank DMEM (as control), hBD3 (10 μg/mL), P.g-LPS (1 μg/mL), or P.g-LPS (1 μg/mL) + hBD3 (10 μg/mL) for 2 h. Next, the cells were collected to measure mRNA expression levels of TLR-2 (A) and TLR-4 (B) by qPCR (a) and phosphorylation levels of the NF-κB p65 subunit (p-p65) by western blotting (C and D). Data are shown as the mean ± SD of three independent experiments. Differences between two groups were compared by unpaired Student's t-test. *, P < 0.05. Fig. 8 . hBD3 altered polarization signature molecule expression in macrophages. RAW 264.7 cells were treated with blank DMEM (as control), hBD3 (10 μg/ mL), P.g-LPS (1 μg/mL), or P.g-LPS (1 μg/mL) + hBD3 (10 μg/mL) for 2 h. Next, the cells were collected to measure mRNA expression levels of iNOS (A), Arg-1 (C), and IL-10 (D) by PCR. The culture supernatants were collected to measure NO by nitrate reductase assay (B). Data are shown as the mean ± SD of three independent experiments. Differences between two groups were compared by unpaired Student's t-test. *, P < 0.05.
D. Cui et al. Molecular Immunology 91 (2017) 65-74 that lipids isolated from P.g-LPS can activate TLR2 on the cell surface, contributing to the role of P.g-LPS in activating TLRs (Hashimoto et al., 2004) . The results of our study showing that P.g-LPS significantly increased the TLR2 mRNA level confirmed this phenomenon. In addition, the expression of IL-10 was up-regulated by hBD3, which was also observed in hBD3-treated mice. Next, we detected the phenotype of macrophages treated with P.g-LPS with or without hBD3. In addition to enhancing the proinflammatory cytokines, it was also reported that P.g-LPS can polarise macrophages into a proinflammatory M1 phenotype to be characterised as proinflammatory (Yu et al., 2016) . In the present study, P.g-LPS polarised RAW 264.7 cells into the M1 phenotype. hBD3 had comprehensive modulatory effects on macrophage polarization. It could suppress M1 macrophage polarization induced by P.g-LPS and inhibit M1 macrophage differentiation even in the absence of another stimulus. Additionally, hBD3 potently induced M2 macrophage differentiation. M2 macrophages secrete high levels of IL-10 and can promote wound healing (Mosser and Edwards, 2008) . Thus, the multi-regulatory effect of hBD3 on the balance of macrophage polarization contributes to its anti-inflammatory ability. This may also be favourable for its protective effect in inflammatory diseases such as periodontitis.
The present study provides insight into the effects of hBD3 applied by intraperitoneal injection and periodontal pocket delivery on the progression of periodontitis aggravated by P.g, which may provide a novel therapeutic strategy for clinical application. Down-regulation of proinflammatory cytokines in macrophages and inhibition of the M1 phenotype are pivotal for the protective effect of hBD3. Notably, hBD3 expression levels vary in different periodontal diseases. Thus, in addition to the short-term effect of hBD3 in periodontitis, long-term investigations are required to confirm the ability of hBD3 to protect the periodontium.
